Carl Zeiss Meditec (ETR:AFX) has been given a €71.00 ($82.56) target price by equities researchers at Deutsche Bank in a research note issued to investors on Tuesday. The brokerage currently has a “neutral” rating on the stock. Deutsche Bank’s price objective points to a potential downside of 14.46% from the stock’s current price.
AFX has been the topic of several other research reports. Commerzbank set a €58.00 ($67.44) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Tuesday, November 27th. Berenberg Bank set a €68.00 ($79.07) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Monday. Kepler Capital Markets set a €62.00 ($72.09) target price on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Tuesday, January 15th. Independent Research set a €74.00 ($86.05) target price on shares of Carl Zeiss Meditec and gave the stock a “sell” rating in a report on Tuesday, January 22nd. Finally, HSBC set a €75.00 ($87.21) target price on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a report on Tuesday, December 4th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus target price of €72.31 ($84.08).
Shares of AFX traded up €0.85 ($0.99) during trading hours on Tuesday, hitting €83.00 ($96.51). The stock had a trading volume of 79,602 shares, compared to its average volume of 94,405. Carl Zeiss Meditec has a 52 week low of €37.53 ($43.64) and a 52 week high of €55.25 ($64.24).
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
See Also: Stock Symbols and CUSIP Explained
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.